RVMD (RVMD) Stock Price & Analysis
RVMD (RVMD) fell 0.40% to USD 210.02 as of September 8, 2026 at 06:58 UTC, according to Nexqual real-time market data.
RVMD last closed at USD 210.02; the session ranged USD 207.48–211.75 on volume of 885,061 shares. Market capitalization is —, with a 52-week range of USD 39.73–224.31 (NMS). Source: Nexqual, September 8, 2026 at 06:58 UTC.
Key Statistics (as of September 8, 2026 at 06:58 UTC)
| Price | USD 210.02 |
|---|---|
| Change | ▼ 0.40% (down) |
| Previous Close | USD 210.02 |
| Open | USD 210.02 |
| Day Range | USD 207.48 – 211.75 |
| 52-Week Range | USD 39.73 – 224.31 |
| Volume | 885,061 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (RVMD)
Nexqual's technical model rates RVMD "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:58 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.35 (neutral) |
| vs SMA50 | Above (USD 196.79) |
| MACD | 4.59 (positive) |
From RVMD's Latest SEC 10-K Filing (filed 2026-02-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
| RLAY | Relay Therapeutics, Inc. | USD 19.04 | ▲ 2.86% |
| BBIO | BridgeBio Pharma, Inc. | USD 74.84 | ▼ 2.17% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| LEGN | Legend Biotech Corporation | USD 21.52 | ▼ 1.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:58 UTC. This page is informational and not investment advice.